News
News
ISS validates novel pharma containment systems for highly potent compounds
ISS recently conducted validation for Isolators and hybrid containment systems using surrogate for highly potent APIs with very low containment target of 10 ng/m3. ISS has conducted containment validation for 200+ devices including negative pressured glovebox Isolators, Ventilated Balance Enclosures, Flexible Film Containment systems, Downflow booths, Split Butterfly Valves and other novel containment devices.